Followers | 3182 |
Posts | 208744 |
Boards Moderated | 2 |
Alias Born | 02/04/2004 |
Tuesday, April 29, 2014 4:06:41 PM
1. FDA approval of Effexor which has already surpassed 3 and a half years of the FDA's ANDA timeline to approval process
2. FDA approval of Protonix which has already surpassed 3 and a half years of the FDA's ANDA timeline to approval process
3. FDA approval of Glucophage which has already surpassed 3 and a half years of the FDA's ANDA timeline to approval process
4. FDA approval of Seroquel which has already surpassed 3+ years of the FDA's ANDA timeline to approval process
5. Positive Rexista study update and movement towards Phase 3 this calendar year(Regabatin trial updates and movement towards Phase 3 as well)
6. Potential new partnership/licensing agreement on Effexor with large up front payment and large milestone payments.
7. Potential new partnership/licensing agreement on Protonix with large up front payment and large milestone payments.
8. Potential new partnership/licensing agreement on Glucophage with large up front payment and large milestone payments.
9. Potential new partnership/licensing agreement on Seroquel with large up front payment and large milestone payments.
10. Strong expectation that IPCI will soon be ringing the Nasdaq Opening Bell once again...as already promised by IPCI themselves on 1 of their next milestone achievements.
11. IPCI expects to have 2 new ANDA's filed this calendar year...with their stated goal being up to four ANDA Filings per year.
12. IPCI may also choose to proceed with developing the value of any 1 of their next pipeline of ANDA's in house...and then license them out for full commercialization for even more lucrative returns than partnership/licensing agreements...as alluded to as a strong possibility at the most recent Roth Conference
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IPCI • PR Newswire (Canada) • 06/08/2023 05:30:00 PM
- Canadian Investment Regulatory Organization Trade Resumption - IPCI • PR Newswire (Canada) • 06/08/2023 05:28:00 PM
- Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results • PR Newswire (Canada) • 06/06/2023 10:00:00 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM